Low-FODMAP Diet May Improve IBS-D Through Effects on Mast Cells and Intestinal Barrier Function

Key Clinical Summary

Low-FODMAP Diet Improves Barrier Function in IBS-D: Mechanistic Trial

• Per Gastroenterology (2026), a translational mechanistic study of 42 Rome IV-defined IBS-D patients found 34 responders and 8 nonresponders after a low-FODMAP diet; colonic barrier function and mast cell activity were assessed before and after intervention, with complementary fecal transfer experiments in animal models.
• Following the low-FODMAP diet, responders demonstrated improved colonic barrier structure/function and reduced mast cell numbers and mediator levels. Pre-diet—but not post-diet—fecal material induced barrier dysfunction in germ-free mice, implicating soluble luminal factors.
• Mechanistic findings identified fecal lipopolysaccharide–TLR4 signaling on colonic mast cells as a mediator of barrier dysfunction. TLR4 antagonism, lipopolysaccharide removal, or mast cell stabilization prevented barrier dysfunction, supporting a biologic mechanism underlying dietary response.

A low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (low-FODMAP) diet may improve diarrhea-predominant irritable bowel syndrome (IBS-D) by reducing mast cell activation and restoring intestinal barrier function, according to a translational study investigating the biologic mechanisms underlying dietary response.

The study evaluated 42 patients with Rome IV-defined IBS-D who underwent assessment of colonic barrier function and mast cell activity before and after a low-FODMAP diet. Researchers also performed mechanistic experiments using fecal samples transferred to animal models.

Of the 42 participants, 34 responded to the dietary intervention and 8 did not. Following the low-FODMAP diet, patients demonstrated significant improvements in colonic barrier structure and function, along with reductions in mast cell numbers and mast cell mediator levels.

Investigators found that pre-diet fecal material induced barrier dysfunction when transferred into germ-free mice, whereas post-diet fecal material did not. Similar findings were observed using fecal supernatants, suggesting that soluble luminal factors contribute to epithelial dysfunction.

Further mechanistic studies identified a role for lipopolysaccharide and toll-like receptor 4 (TLR4) signaling. Removal of lipopolysaccharide and pharmacologic TLR4 antagonism reversed barrier dysfunction induced by pre-diet fecal supernatants. Likewise, barrier dysfunction was absent in TLR4-deficient mice exposed to pre-diet samples.

The study also implicated mast cells as key mediators of this process. Pre-diet fecal supernatants failed to induce barrier dysfunction in mice treated with a mast cell stabilizer or in mast cell-deficient mice. Barrier dysfunction could be restored after reconstitution with wild-type mast cells but not with TLR4-deficient mast cells.

The investigators concluded that FODMAP-associated barrier dysfunction “is mediated by direct activation of the TLR4 receptor on colonic mast cells by fecal lipopolysaccharide.”

Gao J, Lee AA, Abtahi S, et al. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet improves colonic barrier function and mast cell activation in patients with diarrhea-predominant irritable bowel syndrome: A mechanistic trial. Gastroenterology. 2026;170(1):132-147. DOI: 10.1053/j.gastro.2025.07.016